Sands Capital Alternatives, LLC
CIK: 0001846444Latest portfolio: $518.5M · Q4 2025
Holdings
20
Total Value
$518.5M
New Positions
1
Closed Positions
1
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | KVYOKLAVIYO INC | 3,649,678 | $118.5M | 22.86% | +135K | |
| 2 | NUNU HLDGS LTD | 6,861,399 | $114.9M | 22.15% | -314,035 | |
| 3 | BBNXBETA BIONICS INC | 3,570,113 | $108.8M | 20.98% | — | |
| 4 | IKTINHIBIKASE THERAPEUTICS INC | 13,018,965 | $26.7M | 5.15% | +2.1M | |
| 5 | DASHDOORDASH INC | 95,618 | $21.7M | 4.18% | +5K | |
| 6 | CPNGCOUPANG INC | 870,424 | $20.5M | 3.96% | +75K | |
| 7 | IOTSAMSARA INC | 466,190 | $16.5M | 3.19% | -132,724 | |
| 8 | DDOGDATADOG INC | 85,793 | $11.7M | 2.25% | -32,914 | |
| 9 | TOSTTOAST INC | 301,647 | $10.7M | 2.07% | +145K | |
| 10 | BIOABIOAGE LABS INC | 786,353 | $10.4M | 2.01% | — | |
| 11 | MNDYMONDAY COM LTD | 67,868 | $10.0M | 1.93% | +10K | |
| 12 | TTANSERVICETITAN INC | 89,856 | $9.6M | 1.85% | NEW | |
| 13 | TXG10X GENOMICS INC | 481,770 | $7.9M | 1.52% | — | |
| 14 | ABOSACUMEN PHARMACEUTICALS INC | 3,417,075 | $7.2M | 1.39% | — | |
| 15 | TARSTARSUS PHARMACEUTICALS INC | 85,000 | $7.0M | 1.34% | -85,000 | |
| 16 | ACRVACRIVON THERAPEUTICS INC | 2,122,605 | $5.1M | 0.99% | — | |
| 17 | SNOWSNOWFLAKE INC | 20,253 | $4.4M | 0.86% | -6,752 | |
| 18 | TSHATAYSHA GENE THERAPIES INC | 724,873 | $4.0M | 0.77% | — | |
| 19 | CADLCANDEL THERAPEUTICS INC | 405,837 | $2.3M | 0.44% | — | |
| 20 | FIGFIGMA INC | 18,286 | $683K | 0.13% | — |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($1.0878126688104038e+30T)
Technology0.0% ($1.1850516526116661e+27T)
Financial Services0.0% ($114.9M)
Communication Services0.0% ($21.7M)
Consumer Cyclical0.0% ($20.5M)
Filing History
Fund Information
Sands Capital Alternatives, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $518.5M across 20 holdings. The largest position is KLAVIYO INC (KVYO), representing 22.9% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 1 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.